Clinician-Collected Versus Patient-Collected Cervical Pap Smears
NCT ID: NCT01214330
Last Updated: 2024-03-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2011-01-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Begin to determine patient attitudes regarding ease of use and discomfort using SoloPap.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility and Acceptability of Offering Self-sampling to Non-attendees in Primary Care
NCT02698423
Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique.
NCT00474968
Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study
NCT03813576
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
NCT05092022
Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix
NCT00266084
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient-Collected Cervical Pap Smear
women will receive a self Papanicolaou Smear test (SoloPap) in addition to their physician-collected Papanicolaou Smear
Patient-Collected Cervical Pap Smear
Patient-Collected Cervical Papanicolaou Smear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient-Collected Cervical Pap Smear
Patient-Collected Cervical Papanicolaou Smear
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All women at least 18 yrs of presenting for Pap Smear who have not previously participated in this protocol. SoloPap can be performed any day that a woman is not having vaginal bleeding
Exclusion Criteria
* Known pregnancy
* Women who have had a total hysterectomy (cervix removed)
* Women with vaginal bleeding
* Persons who report a history of severe neuropathy or arthritis of the hands or those having other major problems with dexterity of the hands
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mike O'Callaghan Military Hospital
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Crawford, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mke O'Callaghan Federal Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
Las Vegas, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FWH20100177H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.